Searched for
NILOTINIB CAPSULES
Stocks in news: Kwality Walls, AU Small Finance Bank, YES Bank, PB Fintech, Tata PowerIndian markets faced pressure on Friday, losing some recent gains due to cautious global sentiment and profit-taking. Several companies lik...- Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDACipla USA is recalling over 400 cartons of its generic anti-cancer drug Nilotinib Capsules (150 mg and 200 mg) due to a manufacturing issue...
- Cipla recalls over 400 cartons of cancer drug in US: FDACipla USA is recalling over 400 cartons of its anti-cancer drug Nilotinib Capsules. The recall is due to a manufacturing issue where the ca...
- Cipla targets $1 bn US revenue in FY27Cipla aims for $1 billion in US sales by FY27, offsetting Revlimid's patent expiry with new launches, particularly in respiratory generics ...
- Cipla shares in focus after U.S. FDA nod for Leukemia drugCipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib...
- Aurobindo Pharma shares rise 3% after subsidiary signs license for generic version of Nilotinib CapsulesShares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with M...
- Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drugIndia's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...
Load More